These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 15514730)
1. Tartrate-resistant acid phosphatase as a marker of bone metastases in patients with breast cancer and prostate cancer. Lyubimova NV; Pashkov MV; Tyulyandin SA; Gol'dberg VE; Kushlinskii NE Bull Exp Biol Med; 2004 Jul; 138(1):77-9. PubMed ID: 15514730 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of tartrate-resistant acid phosphatase (TRAP) 5b as serum marker of bone metastases in human breast cancer. Capeller B; Caffier H; Sütterlin MW; Dietl J Anticancer Res; 2003; 23(2A):1011-5. PubMed ID: 12820340 [TBL] [Abstract][Full Text] [Related]
3. Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption. Halleen JM Anticancer Res; 2003; 23(2A):1027-9. PubMed ID: 12820342 [TBL] [Abstract][Full Text] [Related]
4. [TARTRAT-RESISTANT ACID PHOSPHATASE AS BONE'S RESORBTION MARKER IN PATIENTS WITH BONE METASTASES]. Dedkov AG; Boychuk SI; Stakhovsky EA; Kukushkina MN; Kovalchuk PA Lik Sprava; 2015; (5-6):104-9. PubMed ID: 27089726 [TBL] [Abstract][Full Text] [Related]
5. Tartrate-resistant acid phosphatase 5b as a serum marker of bone metastasis in breast cancer patients. Chao TY; Ho CL; Lee SH; Chen MM; Janckila A; Yam LT J Biomed Sci; 2004; 11(4):511-6. PubMed ID: 15153786 [TBL] [Abstract][Full Text] [Related]
6. Serum tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of skeletal changes in prostate cancer. Salminen E; Ala-Houhala M; Korpela J; Varpula M; Tiitinen SL; Halleen JM; Väänänen HK Acta Oncol; 2005; 44(7):742-7. PubMed ID: 16227166 [TBL] [Abstract][Full Text] [Related]
7. Tartrate-resistant acid phosphatase 5b activity is a useful bone marker for monitoring bone metastases in breast cancer patients after treatment. Chung YC; Ku CH; Chao TY; Yu JC; Chen MM; Lee SH Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):424-8. PubMed ID: 16537696 [TBL] [Abstract][Full Text] [Related]
8. Tartrate-resistant acid phosphatase (TRAP) as a serum marker for bone resorption in breast cancer patients with bone metastases. Tauchert S; di Liberto A; Cordes T; Thill M; Salehin D; Friedrich M Clin Exp Obstet Gynecol; 2009; 36(4):219-25. PubMed ID: 20101852 [TBL] [Abstract][Full Text] [Related]
10. Tartrate-resistant acid phosphatase 5b is a useful serum marker for extensive bone metastasis in breast cancer patients. Chao TY; Yu JC; Ku CH; Chen MM; Lee SH; Janckila AJ; Yam LT Clin Cancer Res; 2005 Jan; 11(2 Pt 1):544-50. PubMed ID: 15701839 [TBL] [Abstract][Full Text] [Related]
11. Serum TRACP 5b and ICTP as markers of bone metastases in breast cancer. Korpela J; Tiitinen SL; Hiekkanen H; Halleen JM; Selander KS; Väänänen HK; Suominen P; Helenius H; Salminen E Anticancer Res; 2006; 26(4B):3127-32. PubMed ID: 16886645 [TBL] [Abstract][Full Text] [Related]
12. Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis. Chao TY; Wu YY; Janckila AJ Clin Chim Acta; 2010 Nov; 411(21-22):1553-64. PubMed ID: 20599857 [TBL] [Abstract][Full Text] [Related]
13. Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma. Terpos E; de la Fuente J; Szydlo R; Hatjiharissi E; Viniou N; Meletis J; Yataganas X; Goldman JM; Rahemtulla A Int J Cancer; 2003 Sep; 106(3):455-7. PubMed ID: 12845688 [TBL] [Abstract][Full Text] [Related]
14. Serum levels of tartrate-resistant acid phosphatase-5b in breast cancer patients treated with pamidronate. Martinetti A; Seregni E; Ripamonti C; Ferrari L; De Conno F; Miceli R; Pallotti F; Coliva A; Biancolini D; Bombardieri E Int J Biol Markers; 2002; 17(4):253-8. PubMed ID: 12521129 [TBL] [Abstract][Full Text] [Related]
15. Tartrate-resistant acid phosphatase 5b as serum marker of bone metabolism in cancer patients. Mose S; Menzel C; Kurth AA; Obert K; Breidert I; Borowsky K; Böttcher HD Anticancer Res; 2003; 23(3C):2783-8. PubMed ID: 12926113 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of tartrate-resistant acid phosphatase (TRACP) 5b as bone resorption marker in irradiated bone metastases. Mose S; Menzel C; Kurth AA; Obert K; Ramm U; Eberlein K; Boettcher HD; Pichlmeier U Anticancer Res; 2005; 25(6C):4639-45. PubMed ID: 16334155 [TBL] [Abstract][Full Text] [Related]
17. Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption. Halleen JM; Alatalo SL; Suominen H; Cheng S; Janckila AJ; Väänänen HK J Bone Miner Res; 2000 Jul; 15(7):1337-45. PubMed ID: 10893682 [TBL] [Abstract][Full Text] [Related]
18. Value of TRAcP 5b as a diagnostic marker for detection of bone metastases in patients with breast cancer. Hung MJ; Oremek GM Eur J Gynaecol Oncol; 2011; 32(6):615-8. PubMed ID: 22335021 [TBL] [Abstract][Full Text] [Related]
19. Comparison of serum bone resorption markers in the diagnosis of skeletal metastasis. Koizumi M; Takahashi S; Ogata E Anticancer Res; 2003; 23(5b):4095-9. PubMed ID: 14666607 [TBL] [Abstract][Full Text] [Related]
20. Serum tartrate-resistant acid phosphatase 5b is a specific and sensitive marker of bone resorption. Halleen JM; Alatalo SL; Janckila AJ; Woitge HW; Seibel MJ; Väänänen HK Clin Chem; 2001 Mar; 47(3):597-600. PubMed ID: 11238321 [No Abstract] [Full Text] [Related] [Next] [New Search]